why choose us

First received: September 15, 2022

Clinical Trial: Clavulanic Acid for the Treatment of Cocaine Use Disorder

Study Status: Completed

Recruit Status: RECRUITING

Condition: Cocaine Dependence

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-Blind, Placebo-Controlled Phase 2a Pilot Study to Assess the Efficacy and Safety of Clavulanic Acid vs. Placebo for the Treatment of Cocaine Use Disorder

Brief Summary: A dose escalation study to assess the efficacy and safety of Clavulanic Acid (CLAV) vs. placebo (PBO) for the treatment of cocaine use disorder (CUD)

Read more